English
 
Help Privacy Policy Disclaimer
  Advanced SearchBrowse

Item

ITEM ACTIONSEXPORT
 
 
DownloadE-Mail
  PTEN Loss Contributes to Erlotinib Resistance in EGFR-Mutant Lung Cancer by Activation of Akt and EGFR

Sos, M. L., Koker, M., Weir, B. A., Heynck, S., Rabinovsky, R., Zander, T., et al. (2009). PTEN Loss Contributes to Erlotinib Resistance in EGFR-Mutant Lung Cancer by Activation of Akt and EGFR. Cancer Research, 69(8): 1, pp. 3256-3261. Retrieved from http://dx.doi.org/10.1158/0008-5472.CAN-08-4055.

Item is

Files

show Files

Locators

show

Creators

show
hide
 Creators:
Sos, Martin L.1, Author
Koker, Mirjam1, Author
Weir, Barbara A., Author
Heynck, Stefanie1, Author
Rabinovsky, Rosalia, Author
Zander, Thomas, Author
Seeger, Jens M., Author
Weiss, Jonathan1, Author
Fischer, Florian1, Author
Frommolt, Peter, Author
Michel, Kathrin1, Author
Peifer, Martin1, Author
Mermel, Craig, Author
Girard, Luc, Author
Peyton, Michael, Author
Gazdar, Adi F., Author
Minna, John D., Author
Garraway, Levi A., Author
Kashkar, Hamid, Author
Pao, William, Author
Meyerson, Matthew, AuthorThomas, Roman K.1, Author more..
Affiliations:
1Max Planck Institute of Molecular Physiology, Max Planck Society, ou_1753286              

Content

show

Details

show
hide
Language(s): eng - English
 Dates: 2009-04-07
 Publication Status: Issued
 Pages: -
 Publishing info: -
 Table of Contents: -
 Rev. Type: Peer
 Identifiers: eDoc: 431730
URI: http://dx.doi.org/10.1158/0008-5472.CAN-08-4055
 Degree: -

Event

show

Legal Case

show

Project information

show

Source 1

show
hide
Title: Cancer Research
Source Genre: Journal
 Creator(s):
Affiliations:
Publ. Info: -
Pages: - Volume / Issue: 69 (8) Sequence Number: 1 Start / End Page: 3256 - 3261 Identifier: -